Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NB Private Equity Partners Ltd | 31X | Nov 27, 2024 | 18.20 | 0.00 |
NCAB GROUP AB | XB1 | Nov 27, 2024 | 4.74 | -1.54 |
NCC B | NCGB | Nov 27, 2024 | 13.76 | -0.15 |
NCC Group | NZB | Nov 27, 2024 | 1.86 | +0.54 |
NCI | NCL | Nov 27, 2024 | 2.68 | +3.08 |
Ncino | 6NCA | Nov 27, 2024 | 40.20 | 0.00 |
NCR Corporation | NCR1 | Nov 27, 2024 | 13.60 | -2.86 |
NCS Multistage Holdings, Inc. | MUH0 | Nov 27, 2024 | 20.80 | -1.89 |
ND PAPER | N3Y | Nov 27, 2024 | 0.37 | +0.54 |
NE ELECTRIC | NE4H | Nov 27, 2024 | 0.02 | -4.08 |
NEC Corporation | NEC1 | Nov 27, 2024 | 77.26 | +0.76 |
Nedap (Nederlandsche Apparatenf) NV | NE3 | Nov 27, 2024 | 52.20 | -2.97 |
Nedbank Group Ltd. | NCO | Nov 27, 2024 | 15.20 | +0.66 |
NEDERMAN HLDG AB | 5QR | Nov 27, 2024 | 18.12 | -1.41 |
Neinor Homes | 1NN | Nov 27, 2024 | 15.14 | +1.61 |
Nekkar | 0TT | Nov 27, 2024 | 0.81 | -2.42 |
Nektar Therapeutics | ITH | Nov 27, 2024 | 1.00 | -1.96 |
NEL | D7G | Nov 27, 2024 | 0.27 | +0.37 |
Nel ASA Unsponsored ADR (Norway) | D7GA | Nov 27, 2024 | 7.45 | -2.61 |
Nelly Group | CD20 | Nov 27, 2024 | 2.40 | +1.91 |
Nelnet, Inc. | NIJ | Nov 27, 2024 | 103.00 | -0.96 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | Nov 27, 2024 | 18.60 | 0.00 |
Nemetschek SE | NEM | Nov 27, 2024 | 96.90 | -2.17 |
NENT Group B | NEB | Nov 27, 2024 | 0.06 | -0.84 |
Neo Performance Materials Inc | N14 | Nov 27, 2024 | 5.21 | 0.00 |
NEO-NEON | N2L | Nov 27, 2024 | 0.04 | 0.00 |
Neodecortech S.p.a. | FM2 | Nov 27, 2024 | 2.66 | -3.62 |
Neoen S.A. | N1N | Nov 27, 2024 | 39.22 | +1.29 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | Nov 27, 2024 | 12.50 | -0.79 |
Neogen Corporation | NG2 | Nov 27, 2024 | 13.30 | -7.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.